Insulin Validations: 10x scaling into GLP conditions

Scaled bio-production processes from 2L to 20L under GLP-compliant conditions, developed additional production clones to ensure redundancy and process resilience, and conducted optimization of reaction conditions in collaboration with Shilpa Biologics. These efforts build on earlier work selecting commercial-grade expression vectors, scaling from 0.2L to 2L, validating expression systems, and developing purification and analytical methods towards the ultimate goal of commercial-level bio-production (1,000L scale).